Amgen speaks out about bone density concerns with obesity drug
15 hours ago · AMGN. Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe. The company has tried to ...
Amgen dismisses bone density concerns related to its weight-loss …
1 day ago · Nov 13 (Reuters) - Amgen (AMGN.O) said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after those concerns wiped off more than $12 ...
Amgen Shrugs Off Bone Density Concerns Related to Obesity …
1 day ago · Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.
Amgen Suffers Surprise Blow as New Bone Density Safety
1 day ago · Amgen lost more than 7% of its value in trading on Tuesday after reports circulated that its highly anticipated obesity candidate MariTide could have negative effects on bone mineral density, raising concerns that the investigational therapy could aggravate the risk of fractures in patients. The bone marrow density (BMD) data were first spotted ...
New study reveals key protein that could help prevent excessive bone …
May 30, 2024 · In a new study, researchers have discovered a novel role of the Ctdnep1 phosphatase in suppressing osteoclast differentiation and bone resorption.
Scientists Discover a New Hormone that Can Build Strong Bones
Jul 10, 2024 · A newly discovered hormone explains why females can maintain bone density during lactation, when calcium is stripped away to make milk. This discovery could one day have applications to treating fractures, osteoporosis, and other bone diseases.
FDA Approves New Bone-Building Drug for Osteoporosis - News
Romosozumab works by blocking sclerostin – a protein that stops bone from forming. The drug is given by injection once a month for a year (after 12 months, it loses its effectiveness). In clinical trials, romosozumab increased bone density in the spine as much as 15% – about the amount seen in healthy teens – and cut down on spinal fractures.
Scientists discover a new hormone that could build strong bones
Jul 10, 2024 · Researchers at UC San Francisco and UC Davis showed that in mice, the hormone known as 'maternal brain hormone' (CCN3) increases bone density and strength. Their results were published on July...
Long-Standing Puzzle Solved: Scientists Discover a New
Jul 12, 2024 · Researchers at UCSF and UC Davis discovered a hormone, named Maternal Brain Hormone (CCN3), which maintains bone strength in breastfeeding women despite calcium loss. This hormone could potentially treat osteoporosis and aid …
Amgen Defends Its Investigational Monthly Weight Loss
2 days ago · Analysts referred to new public data from a phase one study, showing that the highest dose of MariTide (420 milligrams) was associated with around 4% decrease in bone mineral density over 12 weeks.